Phase III Farletuzumab Trial Fails to Meet Endpoints in Platinum-Sensitive Disease May 02, 2016Vol.- No.-
Study: Reolysin-Paclitaxel Combination Demonstrates Higher Response than Paclitaxel Therapy Alone March 31, 2016Vol.39 No.03
Atezolizumab Immunotherapy Boosts OS Compared to Docetaxel in Phase II Trial March 31, 2016Vol.39 No.03
